This study is looking at new ways to help adults living with HIV (ALHIV) quit smoking and improve their sleep. It's testing two different behavioral health approaches to reduce smoking, called "Health Approach 1" and "Health Approach 2." Both approaches will be combined with standard smoking cessation treatments, which include the medication varenicline and counseling. The study wants to see if these approaches help people stop smoking and sleep better over 13 weeks, with a follow-up at 6 months. You might be able to join if you are 18-75 years old, have HIV, smoke at least 5 cigarettes a day, and want to quit. The study is currently recruiting 200 participants.

Study design

This is a randomized controlled trial involving 200 participants. Participants will be randomly assigned to either Health Approach 1 or Health Approach 2.

What's involved

You would undergo phone and in-person eligibility assessments, including a physical exam, lab tests, and an overnight sleep assessment. If eligible, you would participate in a 13-week program.

Compensation

Not stated in the trial record.

Follow-up

Your progress will be checked at the end of the 13-week program and again 6 months later.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.